Announcements Trials
Browse Landscape

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Biliary Tract Neoplasms 3Breast Neoplasms 2Uterine Neoplasms 1Sarcoma, Ewing 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Lobular 1

Interventions

Cisplatin 15Gemcitabine 14durvalumab 9pembrolizumab 7Oxaliplatin 6Bevacizumab 6Capecitabine 5lenvatinib 4S 1 (combination) 3Liquid Biopsy 3Irinotecan 3Folfox protocol 3Fluorouracil 3Carboplatin 3zanidatamab 2tremelimumab 2envafolimab 2Trastuzumab 2Nivolumab 2Leucovorin 2Injections 2Blood Specimen Collection 2Albumin-Bound Paclitaxel 2trastuzumab deruxtecan 1toripalimab 1tislelizumab 1poly ICLC 1niraparib 1neratinib 1larotrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Liquid Biopsy × 90 days × Clear all
NCT06648057 2026-03-18

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

CHA University

Recruiting
100 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT07142226 2026-03-18

Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC

CHA University

Recruiting
200 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT07151118 2026-03-18

ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer

CHA University

Recruiting
100 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡